Effects of Vasoconstrictors on Liver Tumor Treatment
Author Information
Author(s): D.M. Hemingway, T.G. Cooke, D. Chang, S.J. Grime, S.A. Jenkins
Primary Institution: University Departments of Surgery, Royal Infirmary, Glasgow; Royal Liverpool Hospital
Hypothesis
Can intra-arterial vasoconstrictors improve the delivery of chemotherapy to liver tumors?
Conclusion
Regional delivery of vasoconstrictors significantly increases the retention of a marker in liver tumors compared to normal liver tissue.
Supporting Evidence
- Systemic administration of angiotensin II increased marker retention in normal liver but not in tumors.
- Regional delivery of angiotensin II and phenylephrine resulted in a four-fold increase in marker retention in tumors.
- Ninety minutes after injection, significant marker retention was still observed in tumors compared to controls.
Takeaway
This study found that using certain drugs can help get more medicine to liver tumors, which might help treat them better.
Methodology
Rats with induced liver tumors were treated with angiotensin II and phenylephrine, and the distribution of a radiolabelled marker was measured.
Limitations
The study was conducted in an animal model, which may not fully replicate human conditions.
Participant Demographics
Male hooded Lister rats, 200-250g body weight.
Statistical Information
P-Value
p<0.02
Statistical Significance
p<0.01
Want to read the original?
Access the complete publication on the publisher's website